These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18783305)

  • 81. [Anastrozole-resistant breast cancer responsive to exemestane--a case report].
    Sakurai T; Oura S; Hirai I; Tanino H; Yoshimas T; Kokawa Y; Nishida M; Sasaki R; Kinoshita T; Bessho T; Yokochi H; Nishimura O; Okamura Y
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2051-3. PubMed ID: 15570939
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.
    Prescrire Int; 2001 Aug; 10(54):108-9. PubMed ID: 11718178
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitors.
    Epstein RJ
    Clin Breast Cancer; 2009 Aug; 9(3):184-6. PubMed ID: 19661043
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Thyroid-stimulating hormone elevation misdiagnosed as subclinical hypothyroidism following non-convulsive status epilepticus: a case report.
    Wada A; Suzuki Y; Midorikawa S; Takeuchi S; Kunii Y; Yabe H; Niwa S
    J Med Case Rep; 2011 Sep; 5():432. PubMed ID: 21892965
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [A woman in her twenties with paranoid delusions].
    Mydske S; Haukeland IC; Godø AH; Grytaas MA; Vold JH; Hartwig A
    Tidsskr Nor Laegeforen; 2022 Oct; 142(14):. PubMed ID: 36226421
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Severe prolonged cholestatic hepatitis caused by exemestane.
    Bao T; Fetting J; Mumford L; Zorzi J; Shahverdi K; Jeter S; Herlong F; Stearns V; Lee L
    Breast Cancer Res Treat; 2010 Jun; 121(3):789-91. PubMed ID: 19834799
    [No Abstract]   [Full Text] [Related]  

  • 87. Pomalidomide-induced hypothyroidism.
    Ali SH; Aljenaee K; Wan Mahmood WA; Hatunic M
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 29302330
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Brain Fog in Hypothyroidism: Understanding the Patient's Perspective.
    Ettleson MD; Raine A; Batistuzzo A; Batista SP; McAninch E; Teixeira MCTV; Jonklaas J; Laiteerapong N; Ribeiro MO; Bianco AC
    Endocr Pract; 2022 Mar; 28(3):257-264. PubMed ID: 34890786
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Overt hypothyroidism complicated by complete heart block and severe hyperlipidemia. A case report.
    Mire Waberi M; Abdirahman S; Karataş M; Öcal L; Hassan MO; Awad I; Sheikh Hassan M
    Ann Med Surg (Lond); 2022 Dec; 84():104830. PubMed ID: 36582852
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Thyroid dysfunction from inhibitor of fibroblast growth factor receptor.
    Ahn J; Moyers J; Wong J; Hsueh CT
    Exp Hematol Oncol; 2019; 8():6. PubMed ID: 30820365
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Thyroid function in the etiology of fatigue in breast cancer.
    Kumar NB; Fink A; Levis S; Xu P; Tamura R; Krischer J
    Oncotarget; 2018 May; 9(39):25723-25737. PubMed ID: 29876020
    [TBL] [Abstract][Full Text] [Related]  

  • 92. NOVEL
    Fredette ME; Lombardi KC; Duker AL; Buck CO; Phornphutkul C; Bober MB; Quintos JB
    AACE Clin Case Rep; 2020; 6(1):e1-e4. PubMed ID: 32524007
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Subclinical hypothyroidism unmasked by preeclampsia and ascites.
    Ipadeola A; Nkwocha GC; Adeleye JO
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S173-5. PubMed ID: 24251148
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Severe fatigue due to valproate-induced hypothyroidism in a case of bipolar disorder.
    Kanamori T; Suzuki M; Kaneko Y; Yamada K; Kubo H; Uchiyama M
    Ann Gen Psychiatry; 2020; 19():49. PubMed ID: 32944056
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Recurrent Nausea and Vomiting with Weight Loss Associated with Hypothyroidism: Fact or Myth.
    Singh J; Dinkar A; Kumar N; Kumar K
    Endocr Metab Immune Disord Drug Targets; 2023; 23(6):867-872. PubMed ID: 36475337
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rare Presentation of Subclinical Hypothyroidism from a Lingual Thyroid.
    Windradi C; Soelistijo SA; Mudjanarko SW; Yusuf M
    J ASEAN Fed Endocr Soc; 2021; 36(2):231-232. PubMed ID: 34966213
    [No Abstract]   [Full Text] [Related]  

  • 97. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia.
    Irwig MS
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):248-53. PubMed ID: 25871957
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review.
    Marina D; Rasmussen ÅK; Buch-Larsen K; Gillberg L; Andersson M; Schwarz P
    Cancer Med; 2023 Jan; 12(2):967-982. PubMed ID: 35748065
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thyroid function in postmenopausal breast cancer patients treated with tamoxifen.
    Anker GB; Lønning PE; Aakvaag A; Lien EA
    Scand J Clin Lab Invest; 1998 Apr; 58(2):103-7. PubMed ID: 9587161
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study.
    Digkas E; Smith DR; Wennstig AK; Matikas A; Tegnelius E; Valachis A
    Breast Cancer Res Treat; 2024 Feb; 204(1):79-87. PubMed ID: 38057688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.